Zydus receives tentative approval from USFDA for Sugammadex Injection
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
Cariprazine is an atypical antipsychotic indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder
He holds a Bachelor’s Degree in Science and has joined the company in 2012 and has over 10 years of experience in pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated